Is Reduced Testing or Skip-Lot Testing Acceptable in Pharmaceutical Microbiology?
Is Reduced Testing or Skip-Lot Testing Acceptable in Pharmaceutical Microbiology? Is Reduced Testing or Skip-Lot Testing Acceptable in Pharmaceutical Microbiology? In pharmaceutical microbiology, routine testing is a critical component of ensuring product safety, quality, and regulatory compliance. However, as pharmaceutical processes mature and demonstrate consistent control, a common question arises: Is reduced testing or skip-lot testing acceptable in pharmaceutical microbiology? This article provides a comprehensive, regulatory-aligned explanation of reduced testing and skip-lot testing , including when they may be acceptable, what regulators expect, and how pharmaceutical companies can scientifically justify such approaches. Understanding Reduced Testing and Skip-Lot Testing What Is Reduced Testing in Pharmaceutical Microbiology? Reduced testing refers to a scientifically justified decrease in the frequency, scope, or number of microbiological tests perf...